Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTS: Avodart in Prostate Cancer Biochemical Failure
NCT00558363Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of dutasteride in prostate cancer (PCa), sponsored by GSK. Started Nov 2007; status: completed.
02
Drugs
dutasteride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00558363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558363.